Comparison of In Vitro Activities of Gatifloxacin and Ciprofloxacin against Four Taxa of Rapidly Growing Mycobacteria

ABSTRACT By using current NCCLS broth microdilution methods, we found that gatifloxacin inhibited 90% of the isolates of the Mycobacterium fortuitum group at ≤0.12 μg/ml and 90% of the Mycobacterium chelonae isolates at ≤4 μg/ml. Gatifloxacin was generally fourfold more active than ciprofloxacin. We recommend that both gatifloxacin and ciprofloxacin be tested routinely against rapidly growing mycobacteria.

[1]  R. Wallace,,et al.  Activities of Linezolid against Rapidly Growing Mycobacteria , 2001, Antimicrobial Agents and Chemotherapy.

[2]  R. Wallace,,et al.  Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms , 1992, Antimicrobial Agents and Chemotherapy.

[3]  Kenneth,et al.  Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. , 1999, International journal of systematic bacteriology.

[4]  Ronald N. Jones,et al.  Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997-99). , 2001, Diagnostic microbiology and infectious disease.

[5]  R. Wallace,,et al.  Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy , 1990, Antimicrobial Agents and Chemotherapy.

[6]  R. Wallace,,et al.  Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus , 1996, Antimicrobial agents and chemotherapy.

[7]  R. Wallace,,et al.  PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria , 1995, Journal of clinical microbiology.

[8]  Mary Jane Ferraro,et al.  Performance standards for antimicrobial susceptibility testing : twelfth informational supplement , 2002 .

[9]  R. Wallace,,et al.  Successful treatment of disseminated Mycobacterium chelonae infection with linezolid. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  F. Sultan,et al.  Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Frank,et al.  Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis , 1993, Journal of clinical microbiology.

[12]  A. Bauernfeind.  Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. , 1997, The Journal of antimicrobial chemotherapy.

[13]  R. Wallace,,et al.  Mycobacterium immunogenum sp. nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudo-outbreaks and contaminated metalworking fluids: an international cooperative study on mycobacterial taxonomy. , 2001, International journal of systematic and evolutionary microbiology.

[14]  R. Wallace,,et al.  Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. , 1992, The Journal of infectious diseases.

[15]  R. Wallace,,et al.  The rapidly growing mycobacteria: Characterization and susceptibility testing , 1985 .